Increased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma

Journal of Clinical Immunology

Volumn 27, Issue 4, 2007, Pages 430-437

  Lun, Samantha W M ^a   Wong, C K ^a   Ko, Fanny W S ^a   Hui, David S C ^a   Lam, Christopher W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Allergy; Asthma; CD26; Costimulatory molecules; T lymphocytes

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CCL 22 CHEMOKINE; CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; DIPEPTIDYL PEPTIDASE IV; MEMBRANE ANTIGEN; RANTES; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ASTHMA; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME BLOOD LEVEL; EOSINOPHIL; FEMALE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATORY INFILTRATE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER T CELL; PRIORITY JOURNAL; SUPPRESSOR CELL; TH2 CELL; UPREGULATION;

ADULT; AGED; ANTIGENS, CD26; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CHINA; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 34250200470     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-007-9093-z     Document Type: Article

References (34)

1. Yssel H, Groux H: Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases. Int Arch Allergy Immunol 121:10-8, 2000
2. Larche M, Robinson DS, Kay AB: The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111:450-63, 2003
3. Van DVV, Wierenga-Wolf AF, Driaansen-Soeting PW, et al.: Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus. Clin Exp Allergy 28:110-20, 1998
4. Proost P, Schutyser E, Menten P, et al.: Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98:3554-61, 2001
5. Lambeir AM, Durinx C, Scharpe S, et al.: I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40:209-94, 2003
6. Hoffmann T, Faust J, Neubert K, et al.: Dipeptidyl peptidase IV (CD26) and aminopeptidase N (CD13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences. FEBS 336:61-4, 1993
7. Qin S, Rottman JB, Myers P, et al.: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746-54, 1998
8. Emanuele E, Minoretti P, Martinelli V, et al.: Circulating levels of soluble CD26 are associated with phobic anxiety in women. Prog Neuropsychopharmacol Biol Psychiatry 30:1334-6, 2006
9. Proost P, Struyf S, Loos T, et al.: Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies. Arthritis Res Ther 8:R107, 2006
10. Reinhold D, Bank U, Buhling F, et al.: Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells. Immunology 91:354-60, 1997
11. Willheim M, Ebner C, Baier K, et al.: Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J Allergy Clin Immunol 100:348-55, 1997
12. Busso N, Wagtmann N, Herling C, et al.: Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 166:433-42, 2005
13. Ohnuma K, Yamochi T, Hosono O, et al.: CD26 T cells in the pathogenesis of asthma. Clin Exp Immunol 139:13-6, 2005
14. Chambers CA: The expanding world of co-stimulation: The two-signal model revisited. Trends Immunol 22:217-23, 2001
15. Chen YQ, Shi HZ: CD28/CTLA-4-CD80/CD86 and ICOS-B7RP-1 costimulatory pathway in bronchial asthma. Allergy 61:15-26, 2006
16. Mercer JC, Ragin MJ, August A: Natural killer T cells: Rapid responders controlling immunity and disease. Int J Biochem Cell Biol 37:1337-43, 2005
17. Akbari O, Faul JL, Hoyte EG, et al.: CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 354:1117-29, 2006
18. Proost P, DeMeester I, Schols D, et al.: Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Converstion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Bio Chem 273:7222-7, 1998
19. Proost P, Struyf S, Schols D, et al.: Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. J Bio Chem 274:3988-93, 1999
20. Lun SW, Wong CK, Ko FW, et al.: Aberrant expression of CC and CXC chemokines and their receptors in patients with asthma. J Clin Immunol 26:145-52, 2006
21. Leung TF, Wong CK, Lam CW, et al.: Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children. Eur Respir J 21: 616-620, 2003
22. Lam CW, Fung HK, Vrijmoed LP, et al.: Aetiology of allergic rhinitis in Hong Kong. Allergol Int 47:23-28, 1998
23. American Thoracic Society: Guidelines for the evaluation of impairment/disability in patients with asthma. Am Rev Respir Dis 147:1056-61, 1993
24. American Thoracic Society: Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152:1107-36, 1995
25. Lam KK, Pang SC, Allan WG et al.: Predictive nomograms for forced expiratory volume, forced vital capacity, and peak expiratory flow rate, in Chinese adults and children. Br J Dis Chest 77:390-396, 1983
26. National Asthma Education and Prevention Program: Expert panel report 2: Guidelines for the management of asthma. Bethesda, MD: National Institutes of Health, April 1997 Publication No. 97-4051
27. National Heart, Blood, and Lung Institute: Global strategy for asthma management and prevention: WHO/NHLBI workshop report. Bethesda, MD: National Heart, Lung, and Blood Institute, 1995; Publication No. 95-3659
28. Wong CK, Lun SW, Ko FW, et al.: Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clin Exp Immunol 141:122-9, 2005
29. Baggiolini M: Chemokines and leukocyte traffic. Nature 392:565-8, 1998
30. Pease JE: Asthma, allergy and chemokines. Curr Drug Targets. 7:3-12, 2006
31. Ishii T, Ohnuma K, Murakami A, et al.: CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc Natl Acad Sci U.S.A 98:12138-43, 2001
32. Ohnuma K, Yamochi T, Uchiyama M, et al.: CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells. Mol Cell Biol 25:7743-57, 2005
33. Lee SY, Lee YH, Shin C, et al.: Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 122:171-6, 2002
34. Kruschinski C, Skripuletz T, Bedoui S, et al.: CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model. Clin Exp Immunol 139:17-24, 2005